Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

p21 Half-Life: Protein Degradation Pathway Comparison

CRL4-Cdt2 CRL4-Cdt2 complex PIP-degron (TD motif, residues 156–160) S phase (chromatin-bound p21) 20–30 minutes Dominant pathway during DNA replication; mutation of T156 extends half-life to >2 hours SCF-Skp2 SCF-Skp2 complex Phospho-T145 recognition G1/S tran

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • CRL4-Cdt2
  • CRL4-Cdt2 complex
  • PIP-degron (TD motif, residues 156–160)
  • S phase (chromatin-bound p21)
  • 20–30 minutes
  • Dominant pathway during DNA replication; mutation of T156 extends half-life to >2 hours
  • SCF-Skp2
  • SCF-Skp2 complex
  • Phospho-T145 recognition
  • G1/S transition (cytoplasmic p21)
  • 30–45 minutes
  • Activated by growth factor signalling through AKT; accounts for rapid clearance during mitogenic stimulation
  • Stabilised (DNA damage)
  • E3 ligases inhibited
  • Acetylation at K161/163/164 blocks ubiquitination
  • G1 arrest (stress response)
  • 90–120 minutes
  • p53-dependent transcription + post-translational stabilisation; allows p21 accumulation for cell cycle arrest
  • Quiescent cells
  • Reduced proteasome activity
  • Reduced E3 ligase expression
  • G0 (non-dividing)
  • 60–90 minutes
  • Baseline degradation continues but slowed due to low proteasome throughput and lack of replication-coupled degradation